Moreover, blocking β2-adrenergic receptors has shown therapeutic benefits in clear cell renal cell carcinoma (ccRCC) with the VHL gene’s loss of function by reducing inflammation and oxidative stress [52,53], thus possibly explaining the observed effects on RCC-Shaw and Caki-1 cell lines. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.